ALBHF (Alibaba Health Information Technology) Moat Score: 5/10 (As of Jul. 02, 2026)


ALBHF Alibaba Health Information Technology Ltd ALBHF
55 GF Score
Price $0.41
GF Value $0.69
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology Moat Score?

Alibaba Health Information Technology ALBHF -2.64% 55 Moat Score is 5 as of Jul. 02, 2026. GuruFocus rates ALBHF with a GF Score™ of 55/100 and a GF Value™ of $0.69 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 96.02% on this metric.

Alibaba Health Information Technology has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Alibaba Health Information Technology has Narrow Moat: Alibaba Health benefits from strong brand recognition and network effects within China's digital health sector. However, intense competition and regulatory challenges limit its moat to a solid narrow level.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Alibaba Health Information Technology might have Narrow Moat - Solid narrow moat.

Alibaba Health Information Technology  (OTCPK:ALBHF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Alibaba Health Information Technology Moat Score Related Terms

Alibaba Health Information Technology Moat Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alibaba Health Information Technology Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Moat Score distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's Moat Score falls into.


ALBHF
55GF Score
Alibaba Health Information Technology Ltd ALBHF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Alibaba Health Information Technology (ALBHF) has a Moat Score of 5 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Alibaba Health Information Technology ranks #27 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is Alibaba Health Information Technology's Moat Score too high?
Alibaba Health Information Technology's current Moat Score is 5. Based on the distribution chart, Alibaba Health Information Technology ranks #27 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Moat Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #27 out of 679 companies for Moat Score. This places Alibaba Health Information Technology in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Alibaba Health Information Technology's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.69, compared to a current price of $0.41 — trading 40.6% below its estimated fair value. The current Moat Score is 5. Alibaba Health Information Technology's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current Moat Score is 5 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of $0.41 is trading 40.6% below its estimated GF Value™ of $0.69. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for ALBHF:

  • Moat Score: 5
  • GF Value™: $0.69 vs. price of $0.41 (40.6% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
55GF Score

Get the complete analysis for ALBHF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.41
Price
$0.69
GF Value